Clinical Trial: A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MK-5684 in Male Participants With Moderate Hepatic Impairment
Brief Summary:
Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer.The purpose of this study is to learn what happens to opevesostat in a person's body over time (a pharmacokinetic [PK] study).Researchers will compare what happens to opevesostat in the body when it is given to healthy participants and participants with moderate hepatic (liver) impairment.
Read more